NTx Bio has introduced NTxscribe® FLEX, a benchtop RNA production system built on the company’s continuous flow, hollow fiber bioreactor architecture. The Research Use Only (RUO) platform integrates in vitro transcription through initial purification in a closed, automated run, enabling controlled RNA production with minimal manual steps. FLEX supports adjustable parameters for small research batches through larger translational runs and is designed to preserve integrity in long and complex RNA constructs. GMP capability is planned for early 2027.